These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 37582832)

  • 1. Nanoparticles carrying paclitaxel and anti-miR-221 for breast cancer therapy triggered by ultrasound.
    Zhang L; Ren Z; Lü J; Mo X; Lin J; Li Y; Ma W; Liu P; Shen Y; Zhao Q; Qian L; Cheng X; Yu Z; Zhang B
    Cell Death Discov; 2023 Aug; 9(1):298. PubMed ID: 37582832
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A light-controllable specific drug delivery nanoplatform for targeted bimodal imaging-guided photothermal/chemo synergistic cancer therapy.
    Guo Y; Wang XY; Chen YL; Liu FQ; Tan MX; Ao M; Yu JH; Ran HT; Wang ZX
    Acta Biomater; 2018 Oct; 80():308-326. PubMed ID: 30240955
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Macrophage-Derived Extracellular Vesicles as Drug Delivery Systems for Triple Negative Breast Cancer (TNBC) Therapy.
    Haney MJ; Zhao Y; Jin YS; Li SM; Bago JR; Klyachko NL; Kabanov AV; Batrakova EV
    J Neuroimmune Pharmacol; 2020 Sep; 15(3):487-500. PubMed ID: 31722094
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Folate-receptor-targeted laser-activable poly(lactide-
    Liu F; Chen Y; Li Y; Guo Y; Cao Y; Li P; Wang Z; Gong Y; Ran H
    Int J Nanomedicine; 2018; 13():5139-5158. PubMed ID: 30233177
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Combined chemotherapy for triple negative breast cancer treatment by paclitaxel and niclosamide nanocrystals loaded thermosensitive hydrogel.
    Zhao D; Hu C; Fu Q; Lv H
    Eur J Pharm Sci; 2021 Dec; 167():105992. PubMed ID: 34517104
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dual-mode imaging and therapeutic effects of drug-loaded phase-transition nanoparticles combined with near-infrared laser and low-intensity ultrasound on ovarian cancer.
    Chen S; Liu Y; Zhu S; Chen C; Xie W; Xiao L; Zhu Y; Hao L; Wang Z; Sun J; Chang S
    Drug Deliv; 2018 Nov; 25(1):1683-1693. PubMed ID: 30343601
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effective suppression of triple negative breast cancer by paclitaxel nanoparticles conjugated with transmembrane TNF-α monoclonal antibody.
    Liu J; Wang P; Huang B; Cheng Q; Duan Y; Chen L; Ma T; Zhu C; Li D; Fan W; Yu M
    Int J Pharm; 2022 Aug; 624():121969. PubMed ID: 35803533
    [TBL] [Abstract][Full Text] [Related]  

  • 8. HPA aptamer functionalized paclitaxel-loaded PLGA nanoparticles for enhanced anticancer therapy through targeted effects and microenvironment modulation.
    Duan T; Xu Z; Sun F; Wang Y; Zhang J; Luo C; Wang M
    Biomed Pharmacother; 2019 Sep; 117():109121. PubMed ID: 31252265
    [TBL] [Abstract][Full Text] [Related]  

  • 9. MicroRNA-200c delivered by solid lipid nanoparticles enhances the effect of paclitaxel on breast cancer stem cell.
    Liu J; Meng T; Yuan M; Wen L; Cheng B; Liu N; Huang X; Hong Y; Yuan H; Hu F
    Int J Nanomedicine; 2016; 11():6713-6725. PubMed ID: 28003747
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Imaging-guided photoacoustic drug release and synergistic chemo-photoacoustic therapy with paclitaxel-containing nanoparticles.
    Zhong J; Yang S; Wen L; Xing D
    J Control Release; 2016 Mar; 226():77-87. PubMed ID: 26860283
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Exploring paclitaxel-loaded adenosine-conjugated PEGylated PLGA nanoparticles for targeting triple-negative breast cancer.
    Chaudhari D; Kuche K; Yadav V; Ghadi R; Date T; Bhargavi N; Jain S
    Drug Deliv Transl Res; 2023 Apr; 13(4):1074-1087. PubMed ID: 36528709
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hybrid Cell Membrane-Functionalized Biomimetic Nanoparticles for Targeted Therapy of Osteosarcoma.
    Cai JX; Liu JH; Wu JY; Li YJ; Qiu XH; Xu WJ; Xu P; Xiang DX
    Int J Nanomedicine; 2022; 17():837-854. PubMed ID: 35228800
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Paclitaxel-loaded biodegradable ROS-sensitive nanoparticles for cancer therapy.
    Pandya AD; Jäger E; Bagheri Fam S; Höcherl A; Jäger A; Sincari V; Nyström B; Štěpánek P; Skotland T; Sandvig K; Hrubý M; Mælandsmo GM
    Int J Nanomedicine; 2019; 14():6269-6285. PubMed ID: 31496685
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ultrasound-Mediated Microbubble Destruction (UMMD) Facilitates the Delivery of CA19-9 Targeted and Paclitaxel Loaded mPEG-PLGA-PLL Nanoparticles in Pancreatic Cancer.
    Xing L; Shi Q; Zheng K; Shen M; Ma J; Li F; Liu Y; Lin L; Tu W; Duan Y; Du L
    Theranostics; 2016; 6(10):1573-87. PubMed ID: 27446491
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Co-delivery of cisplatin and paclitaxel by folic acid conjugated amphiphilic PEG-PLGA copolymer nanoparticles for the treatment of non-small lung cancer.
    He Z; Huang J; Xu Y; Zhang X; Teng Y; Huang C; Wu Y; Zhang X; Zhang H; Sun W
    Oncotarget; 2015 Dec; 6(39):42150-68. PubMed ID: 26517524
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Paclitaxel-loaded and A10-3.2 aptamer-targeted poly(lactide-
    Wu M; Wang Y; Wang Y; Zhang M; Luo Y; Tang J; Wang Z; Wang D; Hao L; Wang Z
    Int J Nanomedicine; 2017; 12():5313-5330. PubMed ID: 28794625
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Macrophage-reprogramming upconverting nanoparticles for enhanced TAM-mediated antitumor therapy of hypoxic breast cancer.
    Yoon J; Le XT; Kim J; Lee H; Nguyen NT; Lee WT; Lee ES; Oh KT; Choi HG; Youn YS
    J Control Release; 2023 Aug; 360():482-495. PubMed ID: 37423526
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ultrasound-Triggered Drug Delivery for Breast Tumor Therapy Through iRGD-Targeted Paclitaxel-Loaded Liposome-Microbubble Complexes.
    Zhang J; Wang S; Deng Z; Li L; Tan G; Liu X; Zheng H; Yan F
    J Biomed Nanotechnol; 2018 Aug; 14(8):1384-1395. PubMed ID: 29903054
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mesenchymal stem cells loaded with paclitaxel-poly(lactic-
    Wang X; Gao J; Ouyang X; Wang J; Sun X; Lv Y
    Int J Nanomedicine; 2018; 13():5231-5248. PubMed ID: 30237710
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Co-delivery of paclitaxel (PTX) and docosahexaenoic acid (DHA) by targeting lipid nanoemulsions for cancer therapy.
    Li B; Tan T; Chu W; Zhang Y; Ye Y; Wang S; Qin Y; Tang J; Cao X
    Drug Deliv; 2022 Dec; 29(1):75-88. PubMed ID: 34964421
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.